Growth Potential Target mid-size to large independent and multi-site pharmacies seeking turnkey dispensing, workflow optimization and integrated POS solutions, highlighting Rx30 as a scalable platform supporting both small and high-volume operations.

Revenue Expansion Leverage Opportunities Now enhancements to offer clinics and pharmacies diversified revenue streams through paid clinical opportunities within a broad independent network, positioning Rx30 as a driver for additional revenue.

Strategic Acquisition Capitalize on recent strategic moves and ownership changes, such as the Tabula Rasa asset acquisition, to approach potential customers with a story of integrated, enhanced patient engagement and expanded product footprint.

Tech & Integrations Highlight the platform’s broad vendor interfaces, integrated POS, IV processing, compounding, and accounts receivable capabilities, targeting buyers seeking an all-in-one, tech-forward dispensing solution with strong interoperability.

Financial & Market Position Rx30 within a competitive landscape of mid-market players by emphasizing mid-range revenue, scalable workforce, and a proven growth trajectory under private equity-backed ownership, appealing to buyers and partners seeking stability and expansion.